Definition of miRNAs expression profile in glioblastoma samples: the relevance of non-neoplastic brain reference - PubMed (original) (raw)
Comparative Study
Definition of miRNAs expression profile in glioblastoma samples: the relevance of non-neoplastic brain reference
Michela Visani et al. PLoS One. 2013.
Abstract
Glioblastoma is the most aggressive brain tumor that may occur in adults. Regardless of the huge improvements in surgery and molecular therapy, the outcome of neoplasia remains poor. MicroRNAs are small molecules involved in several cellular processes, and their expression is altered in the vast majority of tumors. Several studies reported the expression of different miRNAs in glioblastoma, but one of the most critical point in understanding glioblastoma miRNAs profile is the comparison of these studies. In this paper, we focused our attention on the non-neoplastic references used for determining miRNAs expression. The aim of this study was to investigate if using three different non-neoplastic brain references (normal adjacent the tumor, commercial total RNA, and epileptic specimens) could provide discrepant results. The analysis of 19 miRNAs was performed using Real-Time PCR, starting from the set of samples described above and the expression values compared. Moreover, the three different normal RNAs were used to determine the miRNAs profile in 30 glioblastomas. The data showed that different non-neoplastic controls could lead to different results and emphasize the importance of comparing miRNAs profiles obtained using the same experimental condition.
Conflict of interest statement
Competing Interests: The authors have declared that no competing interests exist.
Figures
Figure 1. Differences in miRNAs expression.
Scatter plots show miRNAs significantly different between groups. Bars indicate median values. * p<0.05, ** p<0.01 according to Mann-Whitney test. The representation of commercial reference (a pool of normal brain RNA) indicates technical variability, while scatter plots of Normal adjacent the tumor and epileptic specimens show individual variability. N-Ad, Normal adjacent the tumor; Ref, Commercial reference; EP, epileptic.
Similar articles
- miRNAs expression analysis in paired fresh/frozen and dissected formalin fixed and paraffin embedded glioblastoma using real-time pCR.
de Biase D, Visani M, Morandi L, Marucci G, Taccioli C, Cerasoli S, Baruzzi A, Pession A; PERNO Study Group. de Biase D, et al. PLoS One. 2012;7(4):e35596. doi: 10.1371/journal.pone.0035596. Epub 2012 Apr 18. PLoS One. 2012. PMID: 22530056 Free PMC article. - Extensive modulation of a set of microRNAs in primary glioblastoma.
Ciafrè SA, Galardi S, Mangiola A, Ferracin M, Liu CG, Sabatino G, Negrini M, Maira G, Croce CM, Farace MG. Ciafrè SA, et al. Biochem Biophys Res Commun. 2005 Sep 9;334(4):1351-8. doi: 10.1016/j.bbrc.2005.07.030. Biochem Biophys Res Commun. 2005. PMID: 16039986 - miR-155 is up-regulated in primary and secondary glioblastoma and promotes tumour growth by inhibiting GABA receptors.
D'Urso PI, D'Urso OF, Storelli C, Mallardo M, Gianfreda CD, Montinaro A, Cimmino A, Pietro C, Marsigliante S. D'Urso PI, et al. Int J Oncol. 2012 Jul;41(1):228-34. doi: 10.3892/ijo.2012.1420. Epub 2012 Mar 28. Int J Oncol. 2012. PMID: 22470130 - miRNAs as important drivers of glioblastomas: a no-brainer?
Odjélé A, Charest D, Morin P Jr. Odjélé A, et al. Cancer Biomark. 2012;11(6):245-52. doi: 10.3233/CBM-2012-0271. Cancer Biomark. 2012. PMID: 23248182 Review. - The emerging role of tumor-suppressive microRNA-218 in targeting glioblastoma stemness.
Gao X, Jin W. Gao X, et al. Cancer Lett. 2014 Oct 10;353(1):25-31. doi: 10.1016/j.canlet.2014.07.011. Epub 2014 Jul 17. Cancer Lett. 2014. PMID: 25042866 Review.
Cited by
- MicroRNAs as possible biomarkers for diagnosis and prognosis of hepatitis B- and C-related-hepatocellular-carcinoma.
Fiorino S, Bacchi-Reggiani ML, Visani M, Acquaviva G, Fornelli A, Masetti M, Tura A, Grizzi F, Zanello M, Mastrangelo L, Lombardi R, Di Tommaso L, Bondi A, Sabbatani S, Domanico A, Fabbri C, Leandri P, Pession A, Jovine E, de Biase D. Fiorino S, et al. World J Gastroenterol. 2016 Apr 21;22(15):3907-36. doi: 10.3748/wjg.v22.i15.3907. World J Gastroenterol. 2016. PMID: 27099435 Free PMC article. Review. - Artificial microenvironment of in vitro glioblastoma cell cultures changes profile of miRNAs related to tumor drug resistance.
Witusik-Perkowska M, Zakrzewska M, Jaskolski DJ, Liberski PP, Szemraj J. Witusik-Perkowska M, et al. Onco Targets Ther. 2019 May 20;12:3905-3918. doi: 10.2147/OTT.S190601. eCollection 2019. Onco Targets Ther. 2019. PMID: 31190889 Free PMC article. - miRNA Signature of Hepatocellular Carcinoma Vascularization: How the Controls Can Influence the Signature.
Fittipaldi S, Vasuri F, Bonora S, Degiovanni A, Santandrea G, Cucchetti A, Gramantieri L, Bolondi L, D'Errico A. Fittipaldi S, et al. Dig Dis Sci. 2017 Sep;62(9):2397-2407. doi: 10.1007/s10620-017-4654-3. Epub 2017 Jun 21. Dig Dis Sci. 2017. PMID: 28639131 - Similarity in targets with REST points to neural and glioblastoma related miRNAs.
Gebhardt ML, Reuter S, Mrowka R, Andrade-Navarro MA. Gebhardt ML, et al. Nucleic Acids Res. 2014 May;42(9):5436-46. doi: 10.1093/nar/gku231. Epub 2014 Apr 11. Nucleic Acids Res. 2014. PMID: 24728992 Free PMC article. - Identification of dysregulated miRNAs and their regulatory signature in glioma patients using the partial least squares method.
Shou J, Gu S, Gu W. Shou J, et al. Exp Ther Med. 2015 Jan;9(1):167-171. doi: 10.3892/etm.2014.2041. Epub 2014 Oct 31. Exp Ther Med. 2015. PMID: 25452796 Free PMC article.
References
- Ambros V (2004) The functions of animal microRNAs. Nature 431: 350–355. - PubMed
- Iorio MV, Ferracin M, Liu CG, Veronese A, Spizzo R, et al. (2005) MicroRNA gene expression deregulation in human breast cancer. Cancer Res 65: 7065–7070. - PubMed
- Yanaihara N, Caplen N, Bowman E, Seike M, Kumamoto K, et al. (2006) Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell 9: 189–198. - PubMed
- Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, et al. (2005) MicroRNA expression profiles classify human cancers. Nature 435: 834–838. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
No current external funding sources for this study. PERNO study group (Region Emilia Romagna, www.perno.it) contributed reagents. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
LinkOut - more resources
Full Text Sources
Other Literature Sources